3 Patents
- US122698692025Chimeric Antigen Receptor Effector Cell Switches with Humanized Targeting Moieties And/or Optimized Chimeric Antigen Receptor Interacting Domains and Uses Thereof
The Scripps Research Institute
0 cites - 0 cites
- US120051202024Galnac Conjugated Modified Oligonucleotides as Mir-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-effect
Regulus Therapeutics Inc.
0 cites